U.S. FDA clears Pfizer's COVID booster shot for young children
The U.S. Food and Drug Administration has authorized the use of a booster shot of Pfizer and BioNTech's COVID-19 vaccine for children aged 5 to 11.
Full Article
U.S. FDA clears Pfizer's COVID booster shot for young children
CBC.ca
0 shares
1 views
You might like
Related news coverage
Pfizer Says 3-Dose COVID-19 Vaccine Is Effective For Children Under 5
Newsy
Watch VideoThree doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced..
Advertisement
More coverage
FDA Clears COVID Booster Shot For Healthy Kids Ages 5 To 11
Newsy
Watch VideoU.S. regulators on Tuesday authorized a COVID-19 booster shot for healthy 5- to 11-year-olds, hoping an extra vaccine..
-
JAB 'EM YOUNG: FDA approves Pfizer's booster vaccine for children aged 5 to 11 without consulting vaccine advisory panel
NaturalNews.com
-
FDA approves Pfizer booster for kids 5-11
CBS 2
-
FDA clears COVID booster shot for healthy kids ages 5 to 11
SeattlePI.com
-
FDA authorizes Pfizer COVID vaccine booster for children 5 to 11
Delawareonline